- Home
- AMPL vs MDXG Comparison
AMPL vs MDXG Comparison
Compare AMPL & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMPL | MDXG |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 914.7M | 1.0B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | AMPL | MDXG |
|---|---|---|
| Price | $6.40 | $3.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $13.42 | $9.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.8M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.84 | ★ 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | $343,214,000.00 | ★ $418,630,000.00 |
| Revenue This Year | $17.43 | N/A |
| Revenue Next Year | $14.16 | $13.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 14.68 | ★ 19.99 |
| 52 Week Low | $5.51 | $3.03 |
| 52 Week High | $14.27 | $7.99 |
Technical Indicators
Market Signals| Indicator | AMPL | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 47.86 |
| Support Level | $5.75 | $3.11 |
| Resistance Level | $7.73 | $7.39 |
| Average True Range (ATR) | 0.42 | 0.18 |
| MACD | -0.06 | 0.07 |
| Stochastic Oscillator | 29.87 | 84.40 |
Price Performance
Historical ComparisonAbout AMPL Amplitude Inc.
Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.